GSK plc
GSK
#191
Rank
S$147.04 B
Marketcap
S$72.76
Share price
-2.09%
Change (1 day)
45.64%
Change (1 year)

Market capitalization of GSK plc (GSK)

Market cap: S$147.04 Billion

As of March 2026 GSK plc has a market cap of S$147.04 Billion. This makes GSK plc the world's 191th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GSK plc from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026S$147.04 B15.3%
2025S$127.53 B34.93%
2024S$94.51 B-6.15%
2023S$100.70 B4.43%
2022S$96.43 B-34.62%
2021S$147.50 B21.5%
2020S$121.39 B-22.63%
2019S$156.90 B22.27%
2018S$128.33 B8.89%
2017S$117.85 B-13.57%
2016S$136.36 B-2.68%
2015S$140.11 B1.8%
2014S$137.64 B-15.79%
2013S$163.45 B26.37%
2012S$129.34 B-13.3%
2011S$149.18 B13.66%
2010S$131.25 B-14.74%
2009S$153.94 B11.37%
2008S$138.23 B-30.78%
2007S$199.71 B-14.22%
2006S$232.82 B-5.11%
2005S$245.36 B6.9%
2004S$229.52 B2.59%
2003S$223.73 B14.28%
2002S$195.78 B-31.22%
2001S$284.65 B-6.77%
2000S$305.31 B80.28%
1999S$169.35 B-18.58%
1998S$208.01 B44.18%
1997S$144.27 B83.16%
1996S$78.77 B

End of Day market cap according to different sources

On Mar 3rd, 2026 the market cap of GSK plc was reported to be:

S$148.41 Billion
by Nasdaq info icon info icon
S$147.04 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
S$404.62 B 175.18%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$192.67 B 31.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$143.08 B-2.69%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$377.72 B 156.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$398.78 B 171.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$47.93 B-67.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
S$2.32 B-98.42%๐Ÿ‡บ๐Ÿ‡ธ USA